Emer­gen­t's trou­bled Bal­ti­more site gets $100M up­grade

The US drug man­u­fac­tur­ing site most ar­guably in need of an up­grade is now get­ting one.

Emer­gent BioSo­lu­tions had al­ready sched­uled some main­te­nance at the ill-fat­ed Bayview site in Bal­ti­more, but now the CD­MO has pushed up that time­line to up­grade its fa­cil­i­ties. The im­prove­ments comes as Emer­gent awaits word from John­son & John­son which is cur­rent­ly as­sess­ing the fu­ture of its Covid-19 vac­cine pro­duc­tion in the US.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER